(Q45874908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Chi D. Luu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Mariapia A Degli-Esposti

16

object named as

M A Degli-Esposti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

C-M Lai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R P Himbeck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S-Y Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

I Yew-San Yeo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

B K Loh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M W Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Barathi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Villano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C-L Ang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R G van der Most

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

I J Constable

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

D Dismuke

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R J Samulski

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

E P Rakoczy

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

10 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

999-1009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22071974%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2011.169

16 January 2020

exact match

0 references

cites work

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Monitoring ocular drug therapy by analysis of aqueous samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Generation of transgenic mice with mild and severe retinal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Bevacizumab for neovascular ocular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Pegaptanib for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Tears of the retinal pigment epithelium: an old problem in a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Immune responses to AAV in a phase I study for Canavan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

CD8(+) T-cell responses to adeno-associated virus capsid in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Effect of gene therapy on visual function in Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Safety and efficacy of gene transfer for Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Investigation of the cause of death in a gene-therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Development and homeostasis of T cell memory in rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Angiogenesis in myocardial infarction. An acute or chronic process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

7 January 2021

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

7 January 2021

Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

7 January 2021

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

7 January 2021

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

7 January 2021

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.169

7 January 2021